EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2 R1441G mutant mouse model of Parkinson's disease

Philip Wing-Lok Ho iD, Lingfei Li, Hui-Fang Liu, Zoe Yuen-Kiu Choi, Eunice Eun Seo Chang, Shirley Yin-Yu Pang, Yasine Malki, Chi-Ting Leung, Michelle Hiu-Wai Kung, David Boyer Ramsden, Shu-Leong Ho

Brain and Behavior · 2023-02 · 13 (2)

DOI: 10.1002/brb3.2886 ↗

At a glance

Journal article in Brain and Behavior, published online on 2023-01-09. Written by Philip Wing-Lok Ho and 10 co-authors. Institution: Division of Neurology, Department of Medicine, School of Clinical Medicine, University of Hong Kong, Hong Kong, China. Major MEDLINE topics: Neuroblastoma, Parkinson Disease. Cited 19 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: Henry G. Leong Endowed Professorship in Neurology, Health and Medical Research Fund, Tai Hung Fai Charitable Foundation - Edwin S H Leong Research Programme for Parkinson's Disease.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Leucine‐rich repeat kinase 2 (LRRK2) mutation is a common genetic risk factor of Parkinson's disease (PD). Presynaptic dysfunction is an early pathogenic event associated with dopamine (DA) dysregulation in striatum of the brain. DA uptake activity of DA uptake transporter (DAT) affects synaptic plasticity and motor and non‐motor behavior. Synaptogyrin‐3 (SYNGR3) is part of the synaptogyrin family, especially abundant in brain. Previous in vitro studies demonstrated interaction between SYNGR3 and DAT. Reduced SYNGR3 expression was observed in human PD brains with unclear reasons.

Methods

Here, we further explored whether inducing SYNGR3 expression can influence (i) cellular DA uptake using differentiated human SH‐SY5Y neuronal cells, (ii) striatal synaptosomal DA uptake in a mutant LRRK2 R1441G knockin mouse model of PD, and (iii) innate rodent behavior using the marble burying test.

Results

Young LRRK2 mutant mice exhibited significantly lower SYNGR3 levels in striatum compared to age‐matched wild‐type (WT) controls, resembling level in aged WT mice. SYNGR3 is spatially co‐localized with DAT at striatal presynaptic terminals, visualized by immuno‐gold transmission electron microscopy and immunohistochemistry. Their protein–protein interaction was confirmed by co‐immunoprecipitation. Transient overexpression of SYNGR3 in differentiated SH‐SY5Y cells increased cellular DA uptake activity without affecting total DAT levels. Inducing SYNGR3 overexpression by adeno‐associated virus‐7 (AAV7) injection in vivo into striatum increased ex vivo synaptosomal DA uptake in LRRK2 mutant mice and improved their innate marble burying behavior.

Conclusion

Brain SYNGR3 expression may be an important determinant to striatal DA homeostasis and synaptic function. Our preliminary behavioral test showed improved innate behavior after SYNGR3 overexpression in LRRK2 mutant mice, advocating further studies to determine the influence of SYNGR3 in the pathophysiology of DA neurons in PD.

Subjects

MeSH terms (MEDLINE)

NeuroblastomaParkinson DiseaseAgedAnimalsHumansMiceDopamineDopaminergic NeuronsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MutationSynaptogyrins

Author keywords

LRRK2 mutationSYNGR3behavioral testdopamine uptake

Substances

DopamineLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanSynaptogyrinsSyngr3 protein, mouseSYNGR3 protein, human

Authors and institutions

  • Division of Neurology, Department of Medicine, School of Clinical Medicine, University of Hong Kong, Hong Kong, China.
  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

ORCID profiles: Philip Wing-Lok Ho

Funding

  • Henry G. Leong Endowed Professorship in Neurology
  • Health and Medical Research Fund
  • Tai Hung Fai Charitable Foundation - Edwin S H Leong Research Programme for Parkinson's Disease

Cite

APA

Ho, P. W., Li, L., Liu, H. F., Choi, Z. Y., Chang, E. E. S., Pang, S. Y., Malki, Y., Leung, C. T., Kung, M. H., Ramsden, D. B., & Ho, S. L. (2023). In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2 R1441G mutant mouse model of Parkinson's disease. Brain and Behavior, 13(2). https://doi.org/10.1002/brb3.2886

Vancouver

Ho PW, Li L, Liu HF, Choi ZY, Chang EES, Pang SY, et al. In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2 R1441G mutant mouse model of Parkinson's disease. Brain and Behavior. 2023;13(2). doi:10.1002/brb3.2886

BibTeX
@article{Ho2023,
  author = {Ho, Philip Wing-Lok and Li, Lingfei and Liu, Hui-Fang and Choi, Zoe Yuen-Kiu and Chang, Eunice Eun Seo and Pang, Shirley Yin-Yu and Malki, Yasine and Leung, Chi-Ting and Kung, Michelle Hiu-Wai and Ramsden, David Boyer and Ho, Shu-Leong},
  title = {In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2 R1441G mutant mouse model of Parkinson's disease},
  journal = {Brain and Behavior},
  year = {2023},
  volume = {13},
  number = {2},
  doi = {10.1002/brb3.2886}
}
Start for free →